4//SEC Filing
ZIOPHARM ONCOLOGY INC 4
Accession 0001209191-15-050755
$TCRTCIK 0001107421operating
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 6:03 PM ET
Size
7.0 KB
Accession
0001209191-15-050755
Insider Transaction Report
Form 4
BRENNAN MURRAY
Director
Transactions
- Sale
Common Stock
2015-06-04$9.55/sh−5,837$55,743→ 12,500 total - Sale
Common Stock
2015-06-03$9.72/sh−34,163$332,064→ 18,337 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.65 to $9.82, inclusive. The reporting person undertakes to provide to ZIOPHARM Oncology, Inc., any security holder of ZIOPHARM Oncology, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.55 to $9.56, inclusive.
Documents
Issuer
ZIOPHARM ONCOLOGY INC
CIK 0001107421
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001107421
Filing Metadata
- Form type
- 4
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 6:03 PM ET
- Size
- 7.0 KB